Skip to main content

Nonreplicating DNA Viral Vectors for Suicide Gene Therapy

The Adenoviral Vectors

  • Protocol
Suicide Gene Therapy

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 90))

  • 607 Accesses

Abstract

Nonreplicative DNA viral vectors (i.e., adenovirus, herpes simplex virus, adeno-associated virus) have been widely used for suicide gene therapy against cancer because their strong and temporary expression of the transgene fit this purpose. Particularly, nonreplicating “adenoviral” vectors have been used in the largest number of clinical trials among all viral vectors. Thus, this chapter covers the adenovirus type 5-based nonreplicative vector.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. He, T. C., Zhou, S., da Costa, L. T., et al. (1998) A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95, 2509–2514.

    Article  PubMed  CAS  Google Scholar 

  2. Hearing, P. and Shenk, T. (1986) The adenovirus type 5 E1A enhancer contains two functionally distinct domains: one is specific for E1A and the other modulates all early units in cis. Cell 45, 229–236.

    Article  PubMed  CAS  Google Scholar 

  3. Steinwaerder, D. S. and Lieber, A. (2000) Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Ther. 7, 556–567.

    Article  PubMed  CAS  Google Scholar 

  4. Hitt, M. M., Addison, C. L., and Graham, F. L. (1997) Human adenovirus vectors for gene transfer into mammalian cells. Adv. Pharmacol. 40, 137–206.

    Article  PubMed  CAS  Google Scholar 

  5. Kurachi, S., Deyashiki, Y., Takeshita, J., et al. (1999) Genetic mechanisms of age regulation of human blood coagulation factor IX. Science 285, 739–743.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc.

About this protocol

Cite this protocol

Yamamoto, M., Curiel, D.T. (2004). Nonreplicating DNA Viral Vectors for Suicide Gene Therapy. In: Springer, C.J. (eds) Suicide Gene Therapy. Methods in Molecular Medicine™, vol 90. Humana Press. https://doi.org/10.1385/1-59259-429-8:61

Download citation

  • DOI: https://doi.org/10.1385/1-59259-429-8:61

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-971-1

  • Online ISBN: 978-1-59259-429-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics